ICU Medical, Inc. Announces Appointment of William Seeger as Director, Member of Audit and Compliance Committee
February 01, 2022 at 09:01 am EST
Share
ICU Medical, Inc. announced on February 1, 2022, the Board of Directors (the “Board”) has increased the size of the Board from eight to nine members and, upon the recommendation of its Nominating/Corporate Governance Committee, appointed William Seeger to serve as a director of the Company, effective immediately. The Board determined that Mr. Seeger qualifies as an independent director within the meaning of the listing requirements of NASDAQ. Mr. Seeger will serve on the Audit and Compliance Committee of the Company.
Mr. Seeger will stand for election by the Company's stockholders at the 2022 Annual Meeting of Stockholders, which is expected to be held in May 2022.
ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needle free IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy product include Portex BLUselect PVC tracheostomy tubes.
ICU MEDICAL, INC. 
